2014
DOI: 10.1007/s11655-014-1789-8
|View full text |Cite
|
Sign up to set email alerts
|

Anti-proliferative effects of ginsenosides extracted from mountain ginseng on lung cancer

Abstract: Major ginsenosides such as Rb1, Rb2 and Rg1 comprising BX-MG induced apoptosis in lung cancer cells via extrinsic apoptotic pathway rather than intrinsic mitochondrial pathway.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
21
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 30 publications
(23 citation statements)
references
References 25 publications
2
21
0
Order By: Relevance
“…Ginseng extract contains characteristic ringstructure compounds known as ginsenosides, many literature reported that ginsenosides have the effect for anti-tumor. (5)(6)(7) Since 1992, we have extracted and isolated total saponins of panax ginseng (TSPG) from ginseng herb, containing multiple ginsenosides, (8)(9)(10)(11)(12) further purified TSPG using macroporous resin to yield a fraction, termed panaxadiol saponins component (PDS-C) which contains 5 ginsenosides. PDS-C was formulated into capsule named as Pai-Neng-Da (派能 达), for which we have been granted a patent by China Food and Drug Administration (CFDA) in 2010 to treat pancytopenia from various causes.…”
mentioning
confidence: 99%
“…Ginseng extract contains characteristic ringstructure compounds known as ginsenosides, many literature reported that ginsenosides have the effect for anti-tumor. (5)(6)(7) Since 1992, we have extracted and isolated total saponins of panax ginseng (TSPG) from ginseng herb, containing multiple ginsenosides, (8)(9)(10)(11)(12) further purified TSPG using macroporous resin to yield a fraction, termed panaxadiol saponins component (PDS-C) which contains 5 ginsenosides. PDS-C was formulated into capsule named as Pai-Neng-Da (派能 达), for which we have been granted a patent by China Food and Drug Administration (CFDA) in 2010 to treat pancytopenia from various causes.…”
mentioning
confidence: 99%
“…In a recent study, it was demonstrated that butanolic extract of mountain ginseng had anti-proliferative and pro-apoptotic effects on A549 human lung cancer cells via modulation of the expression and/or activity of p53, caspase-3 and nuclear factor (NF)-κB (8). Furthermore, a previous study by our group provided evidence that Rb1, Rb2 and Rg1, three of the most abundant ginsenosides in the ginseng extract, induced apoptosis in A549 cells through extrinsic (death receptor-mediated) apoptotic pathways (9). In addition, there is clinical evidence that red ginseng powder effectively enhances postoperative immunity and survival in patients with stage III gastric cancer (10), suggesting the potential clinical applications of ginseng preparations against gastric cancer.…”
Section: An Enzymatically Fortified Ginseng Extract Inhibits Prolifermentioning
confidence: 78%
“…Bcl-2, B-cell lymphoma 2; Bax, Bcl-2-associated X protein; p-mTOR, phosphorylated mammalian target of rapamycin; PKB, protein kinase B; IκBα, nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor α; GBX, ginseng butanol extract; FGX, fortified ginseng extract. quantities of Rb1, inhibits growth and induces apoptosis of A549 human lung cancer cells (9), implying a positive role of Rb1 on the GBX-induced anti-growth and pro-apoptotic effects. In the present study, using HPLC-UV analysis, it was demonstrated that five ginsenosides, including Rh1, Rb1, Rg3(R), compound K and Rh2, were enriched in FGX compared with the ginsenoside profile in GBX.…”
Section: Discussionmentioning
confidence: 97%
“…A total of 7 ginsenosides, including Rg1, Re, Rf, Rb1, Rc, Rb2 and F1, were present in the GBX. By contrast, 5 ginsenosides, including Rh1, Rg3(S), Rg3(R), compound K and Rh2, were exclusively detected in MRGX (6,10 Cell viability assay. Cells (5x10 3 /well) were placed in a 96-well plate.…”
Section: Methodsmentioning
confidence: 88%